Trial of DFP-10917 vs Non-Intensive or Intensive Reinduction for AML Patients in 2nd/3rd/4th Salvage
Delta-Fly Pharma, Inc.
Delta-Fly Pharma, Inc.
EpicentRx, Inc.
Cornerstone Pharmaceuticals
RTOG Foundation, Inc.
M.D. Anderson Cancer Center
Tufts Medical Center
University of Florida
Sun Yat-sen University
French Innovative Leukemia Organisation
Children's Hospital of Philadelphia
SWOG Cancer Research Network
SWOG Cancer Research Network
St. Jude Children's Research Hospital
Gustave Roussy, Cancer Campus, Grand Paris